This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Christopher Ing, PhD
Chief Science Officer at ProteinQuire
Speaker

Profile

Chris is the co-founder and CSO of ProteinQure, a biotechnology company focused on the development of next-generation protein-based therapeutics. He received a PhD in Biochemistry at the University of Toronto focusing on structural biology and biophysics of ion channels, enzymes, and membrane receptors. Previously, he studied Theoretical Chemistry and Computational Physics at the University of Waterloo. He currently leads computational chemistry methods development and applications at ProteinQure, based in Toronto, Canada. He is passionate about cross-disciplinary collaboration to design novel synthetic protein libraries, new protein modalities, and better data-driven strategies for rational drug design.

Agenda Sessions

  • Code to First-in-Human: AI-Designed Peptide Drug Conjugates with Efficacy in Preclinical Models of Breast Cancer

    17:00